sing purity based messages to increase intention to receive the HPV vaccine

Not Applicable

• Conditions: Sexually transmitted disease awareness; Infections and Infestations

• Registration Number: ISRCTN51541314
• Lead Sponsor: Yale School of Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-12
• Last Update Posted: 28 September 2020
• Study Completion: 2020-10-20

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 2556

Inclusion Criteria

1. Between 18 and 23 years of age (inclusive)
2. Resident of the United States
3. Has received no more than 2 doses of the HPV vaccine

Exclusion Criteria

1. Has completed the HPV vaccine series (3 or more doses)
2. Has already completed the survey

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intent to receive the HPV vaccine, measured once during a post-intervention survey administered immediately after the visual message has been reviewed by the participant. (The method of measurement is a single question asking if the participants intend to initiate [if they have received 0 HPV vaccine doses) or continue (if they have received 1-2 HPV vaccine doses] the HPV vaccine series)

Secondary Outcome Measures

Name	Time	Method
<br> 1. Vaccine confidence as measured by the Vaccine Confidence Scale at post intervention<br> 2. Purity/liberty measured using the moral foundations questionnaire before the intervention<br>